ICER To Test Principle Of Fair Access To Fairly Priced Pharmaceuticals ICER is testing the principle of fair access to fairly priced pharmaceuticals, and looking for possible barriers that could impede sustainable access to medical technologies. Specifically, ICER has convened a multi-stakeholder working group to advise its new annual initiative launched in May.